ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 42 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $88,000 | +7.3% | 67,922 | +12.4% | 0.00% | 0.0% |
| Q2 2018 | $82,000 | +20.6% | 60,422 | +29.2% | 0.00% | 0.0% |
| Q1 2018 | $68,000 | -29.2% | 46,784 | +10.1% | 0.00% | 0.0% |
| Q4 2017 | $96,000 | -15.8% | 42,484 | +26.9% | 0.00% | 0.0% |
| Q3 2017 | $114,000 | +153.3% | 33,484 | +166.1% | 0.00% | – |
| Q2 2017 | $45,000 | +1025.0% | 12,584 | +1240.1% | 0.00% | – |
| Q3 2016 | $4,000 | +100.0% | 939 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | -81.8% | 939 | -58.8% | 0.00% | – |
| Q1 2016 | $11,000 | -68.6% | 2,280 | -74.5% | 0.00% | – |
| Q4 2015 | $35,000 | -5.4% | 8,949 | -5.3% | 0.00% | -100.0% |
| Q3 2015 | $37,000 | +42.3% | 9,449 | +70.0% | 0.00% | – |
| Q2 2015 | $26,000 | -16.1% | 5,557 | +21.9% | 0.00% | – |
| Q1 2015 | $31,000 | +3.3% | 4,557 | -50.7% | 0.00% | – |
| Q4 2014 | $30,000 | – | 9,245 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 5,292,156 | $7,674,000 | 1.12% |
| Northeast Financial Consultants Inc | 732,265 | $1,061,000 | 0.36% |
| Family Management Corp | 10,424 | $15,000 | 0.01% |
| AJ WEALTH STRATEGIES, LLC | 15,000 | $22,000 | 0.01% |
| Poehling Capital Management, INC. | 3,302 | $5,000 | 0.00% |
| A.R.T. Advisors, LLC | 48,692 | $70,000 | 0.00% |
| Virtu Financial LLC | 34,383 | $50,000 | 0.00% |
| Founders Capital Management | 3,000 | $4,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 151,854 | $220,000 | 0.00% |
| BEACON INVESTMENT ADVISORY SERVICES, INC. | 10,500 | $15,000 | 0.00% |